Skip to content
DefDex

Federal award

DMS PHARMACEUTICAL GROUP INC

SPE2D021D0004

Contract vehicle (IDV)IDV: ceiling is not spending

Obligated and Ceiling

Obligated (net)
$0.00
Vehicle ceiling (not spending)
$44,163,524.36
Current value
—
Gross positive obligations
$0.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
Owner company
DMS Pharmaceutical GroupBasis direct: the recipient is the company's own reviewed UEI.
Reported parent
DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
Awarding agency
Department of Defense · sub-agency 97AS · office SPE2D0
Funding agency
Department of Defense · sub-agency 97AS
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
PIID
SPE2D021D0004
Award type code
B
Actions
23 · Mar 22, 2021 to Jul 6, 2026
Why it is listed
contract vehicle (IDV)

Open this award on USAspending →

Action History23

Award actions
DateFYModAction typeObligationCompany in company totals
Jul 6, 2026FY2026P00027D$0.00
May 29, 2026FY2026P00026D$0.00
May 20, 2026FY2026P00025D$0.00
May 14, 2026FY2026P00024M$0.00
Mar 19, 2026FY2026P00023G$0.00
Mar 16, 2026FY2026P00022D$0.00
Mar 5, 2026FY2026P00021D$0.00
Nov 20, 2025FY2026P00020D$0.00
Oct 20, 2025FY2026P00019D$0.00
Sep 11, 2025FY2025P00018D$0.00
Jun 27, 2025FY2025P00017M$0.00
May 1, 2025FY2025P00016D$0.00
Mar 19, 2025FY2025P00015G$0.00
Mar 18, 2025FY2025P00014M$0.00
Dec 17, 2024FY2025P00013M$0.00
Mar 20, 2023FY2023P00007G$0.00
Mar 17, 2023FY2023P00006M$0.00
Dec 15, 2022FY2023P00005M$0.00
Sep 14, 2022FY2022P00004M$0.00
Mar 21, 2022FY2022P00003G$0.00
Mar 17, 2022FY2022P00002M$0.00
Jul 29, 2021FY2021P00001M$0.00
Mar 22, 2021FY20210—$0.00

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.